Characterization of Exosomes Platelets-released

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-60
SponsorCentro Cardiologico Monzino

About this trial

Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.

Eligibility criteria

Qualifiers

subjects without known pathologies

Disqualifiers

individuals with gastrointestinal diseases,

individuals with history of hepatic diseases,

individuals with history of urogenital diseases,

individuals with history of hematological diseases,

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

175 Participants
are grouped into 1 trial group

Sponsors and collaborators

Centro Cardiologico Monzino

Lead sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Collaborator